Care of inflammatory bowel disease patients in remission

Subramanian, C. R.; Triadafilopoulos, George

doi:10.1093/gastro/gow032

Cited by 13 publications

(8 citation statements)

References 128 publications

(128 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Although IBD is marked by its chronic, unpredictable nature, patients can and do experience relief from active disease during periods of remission; during which research has shown differences in anxiety or depression rates. 13,14 Based upon the EST assertions stated above; remission would likely serve to moderate the relationship between IBD and PTSD symptomology as a time period with decreased physical symptoms and thus decreased perceptions of threat. In addition, patients' expectations of the longevity of their remission may similarly serve to decrease perceptions of threat.…”

Section: Illness-induced Ptsd and Enduring Somatic Threatmentioning

confidence: 99%

Moderating the Relationship Between Ulcerative Colitis and Crohn’s Disease and Symptoms of PTSD

Fuss

Lease

2022

Journal of Clinical Gastroenterology

View full text Add to dashboard Cite

Goals: This study examined whether inflammatory bowel disease (IBD) patients endorse clinically significant symptoms of post-traumatic stress disorder (PTSD), and tested whether remission status and remission expectations effectively moderate the relationship between endorsements of PTSD symptoms and aspects of IBD. Background Study: The enduring somatic threat model speaks to the presentation of symptoms of trauma that result from ongoing somatic concerns rather than discrete external events. Literature shows patients living with acute conditions experience symptoms of PTSD; however, few studies extend this to the IBD population. In addition, literature suggests remission may serve as a protective factor for the impact of IBD; as such, aspects of remission may serve as moderators in the relationship between aspects of IBD and PTSD symptoms. Results: Among a sample of adults with IBD, results showed that 32.8% of participants met the established cutoff for PTSD symptoms warranting further diagnostic evaluation. The findings further showed several aspects of remission moderated the relationship between multiple distinct IBD related concerns and PTSD symptoms. Conclusions: Given the results of this study, it would be beneficial for providers to maintain awareness of the potential impact of PTSD symptoms, including the ways in which these symptoms may influence patient engagement/presentation. Ultimately, these results inform efforts to continue appropriate referral to mental health professionals for follow up.

show abstract

Section: Illness-induced Ptsd and Enduring Somatic Threatmentioning

confidence: 99%

Moderating the Relationship Between Ulcerative Colitis and Crohn’s Disease and Symptoms of PTSD

Fuss

Lease

2022

Journal of Clinical Gastroenterology

View full text Add to dashboard Cite

show abstract

“…Nutrient composition of daily diets including protein, fat, carbohydrate and dietary fibre have different effects on IBD management [41]. Therefore, nutrition interventions may play an important role in the improvement of IBD symptoms and in disease remission [42]. In the past few years, several dietary interventions have been studied for potential therapeutic effects on IBD [43].…”

Section: Introductionmentioning

confidence: 99%

FODMAPs, inflammatory bowel disease and gut microbiota: updated overview on the current evidence

2022

View full text Add to dashboard Cite

Purpose Based on the fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAP) hypothesis, the low-FODMAP diet has been suggested as a potential therapeutic approach for inflammatory bowel disease (IBD) with promising results on disease management. However, this diet implies a specific broad food restriction, which potentially increases the risk of nutritional deficiencies and may aggravate gut microbiota dysbiosis of IBD patients. The aim of the present study is to review the effect of individual FODMAPs on the human gut microbiota. In addition, this narrative review provides an updated overview of the use of the low-FODMAP diet in IBD, namely the implementation, advantages, limitations, and the impact on the gut microbiota. Methods The literature search strategy was applied to PubMed and Web of Science using relevant keywords, IBD, FOD-MAPs, Fructose, Lactose, Polyols, FOS, GOS, low-FODMAP diet and gut microbiota. Results Current data suggest that the low-FODMAP diet may effectively improve clinical outcomes in the management of IBD and ensure better quality of life for IBD patients. However, there is evidence highlighting some issues of concern, particularly the adequacy of the diet and the impact on the gut microbiota. The various FODMAP types differently modulate the gut microbiota. Conclusion IBD management should be achieved with the least possible dietary restriction to avoid detrimental consequences, particularly on nutritional adequacy and gut microbiota. Thus, it is important to individualize and monitor the nutrition intervention. Further studies are required to better characterize the relationship between diet, the gut microbiota, and IBD to support the generalization of this approach for clinical practice in IBD therapy and management.

show abstract

“…This approach aims to support treatment, care and disease management, and reduce avoidable face-to-face consultations between doctor and patient [ 6 ]. Within IBD, patients daily life experience of the disease and changes herein associates with the state of disease and possibly need of action, thereby being a suitable condition for digital PRO assessment [ 7 , 8 ]. Use of digital PROs also has the potential to increase patient empowerment and improve healthcare [ 1 , 2 , 9 ].…”

Section: Introductionmentioning

confidence: 99%

Digital patient-reported outcomes in inflammatory bowel disease routine clinical practice: the clinician perspective

Nielsen

Appel

Larsen

et al. 2022

J Patient Rep Outcomes

View full text Add to dashboard Cite

Background Use of digital health services, such as digital patient-reported outcomes, depends on many different human factors as well as digital design solutions. One factor is clinicians’ attitude towards the system, their reasoning behind the using system and their perceptions of patients’ ability to engage with digital health systems. This study aimed to explore hospital clinicians’ attitudes towards digital patient-reported outcomes used in the routine care and treatment of inflammatory bowel disease, and to explore the potential role of clinicians’ attitudes in influencing patients’ use of digital patient-reported outcomes. Results Twelve clinicians using digital patient-reported outcome assessments in the care of inflammatory bowel disease were interviewed about their experiences of, and perspectives on, using this service. Most participants supported the use of digital patient-reported outcome assessments in the care of most patients. Participants reported that most patients found the digital solution easy to use. They perceived digital patient-reported outcomes to have three main purposes: prioritising resources; improving patients’ quality of life; and improving quality of care. The patient-clinician relationship was of great importance to participants. Participants varied in their intention to use digital PRO, as some viewed the system as a positive but optional add-on for patients, whilst others intended to use the system with all eligible patients. Conclusion Clinicians’ general support of using digital patient-reported outcomes might facilitate their use among patients with inflammatory bowel disease. The participants saw benefits in doing so for patients, clinicians and the wider health service. Clinicians’ attitudes towards the use of digital PRO in the care of their patients may influence patients’ uptake of health service.

show abstract

Care of inflammatory bowel disease patients in remission

Cited by 13 publications

References 128 publications

Moderating the Relationship Between Ulcerative Colitis and Crohn’s Disease and Symptoms of PTSD

Moderating the Relationship Between Ulcerative Colitis and Crohn’s Disease and Symptoms of PTSD

FODMAPs, inflammatory bowel disease and gut microbiota: updated overview on the current evidence

Digital patient-reported outcomes in inflammatory bowel disease routine clinical practice: the clinician perspective

Contact Info

Product

Resources

About